Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Ventas assumed with a Neutral at Mizuho » 07:24
07/14/21
07/14
07:24
07/14/21
07:24
VTR

Ventas

$58.96 /

-0.48 (-0.81%)

Mizuho analyst Haendel…

Mizuho analyst Haendel St. Juste assumed coverage of Ventas with a Neutral rating and $45 price target following an analyst departure. The rating and price target are unchanged.

ShowHide Related Items >><<
VTR Ventas
$58.96 /

-0.48 (-0.81%)

VTR Ventas
$58.96 /

-0.48 (-0.81%)

07/01/21
Fly Intel: Top five analyst downgrades
07/01/21 BofA
Ventas downgraded to Neutral from Buy at BofA
07/01/21 BTIG
New Senior Investment downgraded to Neutral from Buy at BTIG
06/30/21 Scotiabank
Ventas price target raised to $63 from $61 at Scotiabank
VTR Ventas
$58.96 /

-0.48 (-0.81%)

VTR Ventas
$58.96 /

-0.48 (-0.81%)

Over a month ago
Downgrade
Fly Intel: Top five analyst downgrades » 09:53
07/01/21
07/01
09:53
07/01/21
09:53
MU

Micron

$80.80 /

-4.18 (-4.92%)

, GSHD

Goosehead Insurance

$125.00 /

-2.32 (-1.82%)

, VTR

Ventas

$56.58 /

-0.52 (-0.91%)

, BVS

Bioventus

$15.79 /

-1.76 (-10.03%)

, EIX

Edison International

$57.45 /

-0.395 (-0.68%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Micron (MU) downgraded to Hold from Buy at Summit Insights with analyst Kinngai Chan warning that the favorable memory demand-supply dynamics will peak in the second half of 2021 due to seasonal build and also cites changes in inventory management tactics by many of Micron's customers. 2. Goosehead Insurance (GSHD) downgraded to Neutral from Overweight at JPMorgan with analyst Pablo Singzon seeing a balanced risk/reward at current share levels. 3. Ventas (VTR) downgraded to Neutral from Buy at BofA with analyst Joshua Dennerlein saying he has "a mixed view" on the recently announced New Senior Investment (SNR) acquisition as he is positive on the initial financial accretion but negative on weaker demographics. 4. Bioventus (BVS) downgraded to Neutral from Buy at Goldman Sachs with analyst Amit Hazan citing valuation for the downgrade with the stock nearing the 12-month target. 5. Edison International (EIX) downgraded to Sector Weight from Overweight at KeyBanc with analyst Sophie Karp saying the stock trades at a material discount to the larger regulated peer group, but the company offers no material catalysts in the short term that can narrow that discount. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, .click here.

ShowHide Related Items >><<
VTR Ventas
$56.58 /

-0.52 (-0.91%)

MU Micron
$80.80 /

-4.18 (-4.92%)

GSHD Goosehead Insurance
$125.00 /

-2.32 (-1.82%)

EIX Edison International
$57.45 /

-0.395 (-0.68%)

BVS Bioventus
$15.79 /

-1.76 (-10.03%)

MU Micron
$80.80 /

-4.18 (-4.92%)

07/01/21 KeyBanc
Micron price target raised to $120 from $115 at KeyBanc
07/01/21 Morgan Stanley
Micron 'delivered on fairly high expectations,' says Morgan Stanley
07/01/21 Susquehanna
Texas Instruments price target raised to $230 from $220 at Susquehanna
07/01/21 UBS
Micron price target lowered to $110 from $120 at UBS
GSHD Goosehead Insurance
$125.00 /

-2.32 (-1.82%)

07/01/21 JPMorgan
Goosehead Insurance downgraded to Neutral from Overweight at JPMorgan
06/25/21 Piper Sandler
Goosehead Insurance initiated with an Overweight at Piper Sandler
05/24/21 JPMorgan
BRP Group price target lowered to $30 from $33 at JPMorgan
05/24/21 JPMorgan
Goosehead Insurance assumed with an Overweight at JPMorgan
VTR Ventas
$56.58 /

-0.52 (-0.91%)

07/01/21 BofA
Ventas downgraded to Neutral from Buy at BofA
07/01/21 BTIG
New Senior Investment downgraded to Neutral from Buy at BTIG
06/30/21 Scotiabank
Ventas price target raised to $63 from $61 at Scotiabank
06/30/21 RBC Capital
Ventas price target raised to $65 from $62 at RBC Capital
BVS Bioventus
$15.79 /

-1.76 (-10.03%)

07/01/21 Goldman Sachs
Bioventus downgraded to Neutral from Buy at Goldman Sachs
03/08/21 Canaccord
Canaccord starts 'medtech execution story' Bioventus with Buy
03/08/21 JPMorgan
Bioventus initiated with an Overweight at JPMorgan
03/08/21 Morgan Stanley
Bioventus initiated with an Overweight at Morgan Stanley
EIX Edison International
$57.45 /

-0.395 (-0.68%)

06/30/21 KeyBanc
Edison International downgraded to Sector Weight from Overweight at KeyBanc
06/11/21 Mizuho
Edison International price target raised to $77 from $68 at Mizuho
05/25/21 Barclays
Edison International price target raised to $65 from $64 at Barclays
04/28/21 Wells Fargo
Edison International price target raised to $72 from $66 at Wells Fargo
VTR Ventas
$56.58 /

-0.52 (-0.91%)

MU Micron
$80.80 /

-4.18 (-4.92%)

GSHD Goosehead Insurance
$125.00 /

-2.32 (-1.82%)

EIX Edison International
$57.45 /

-0.395 (-0.68%)

BVS Bioventus
$15.79 /

-1.76 (-10.03%)

  • 11
    Feb
MU Micron
$80.80 /

-4.18 (-4.92%)

VTR Ventas
$56.58 /

-0.52 (-0.91%)

MU Micron
$80.80 /

-4.18 (-4.92%)

BVS Bioventus
$15.79 /

-1.76 (-10.03%)

MU Micron
$80.80 /

-4.18 (-4.92%)

Downgrade
Ventas downgraded to Neutral from Buy at BofA » 07:58
07/01/21
07/01
07:58
07/01/21
07:58
VTR

Ventas

$57.10 /

-0.32 (-0.56%)

, SNR

New Senior Investment

$8.78 /

-0.06 (-0.68%)

BofA analyst Joshua…

BofA analyst Joshua Dennerlein downgraded Ventas (VTR) to Neutral from Buy with a price target of $62, down from $66. He has "a mixed view" on the recently announced New Senior Investment (SNR) acquisition as he is positive on the initial financial accretion but negative on weaker demographics, Dennerlein tells investors. He is also concerned that Ventas has not in his view laid out a clear strategy for improving its existing portfolio, which was underperforming peers pre-pandemic, the analyst added.

ShowHide Related Items >><<
VTR Ventas
$57.10 /

-0.32 (-0.56%)

SNR New Senior Investment
$8.78 /

-0.06 (-0.68%)

VTR Ventas
$57.10 /

-0.32 (-0.56%)

07/01/21 BTIG
New Senior Investment downgraded to Neutral from Buy at BTIG
06/30/21 Scotiabank
Ventas price target raised to $63 from $61 at Scotiabank
06/30/21 RBC Capital
Ventas price target raised to $65 from $62 at RBC Capital
06/28/21 BMO Capital
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively'
SNR New Senior Investment
$8.78 /

-0.06 (-0.68%)

06/30/21 Colliers
New Senior Investment downgraded to Neutral from Buy at Colliers
06/30/21 Capital One
New Senior Investment downgraded to Equalweight from Overweight at Capital One
VTR Ventas
$57.10 /

-0.32 (-0.56%)

VTR Ventas
$57.10 /

-0.32 (-0.56%)

SNR New Senior Investment
$8.78 /

-0.06 (-0.68%)

Downgrade
New Senior Investment downgraded to Neutral from Buy at BTIG » 06:51
07/01/21
07/01
06:51
07/01/21
06:51
SNR

New Senior Investment

$8.78 /

-0.06 (-0.68%)

, VTR

Ventas

$57.10 /

-0.32 (-0.56%)

BTIG analyst Michael…

BTIG analyst Michael Gorman downgraded New Senior Investment (SNR) to Neutral from Buy after the company agreed to be acquired by Ventas (VTR) in an all-stock transaction. The current offer represents fair value on a 2022 net operating income stream that includes a significant recovery from the Q1 run rate, the analyst tells investors in a research note.

ShowHide Related Items >><<
VTR Ventas
$57.10 /

-0.32 (-0.56%)

SNR New Senior Investment
$8.78 /

-0.06 (-0.68%)

SNR New Senior Investment
$8.78 /

-0.06 (-0.68%)

06/30/21 RBC Capital
Ventas price target raised to $65 from $62 at RBC Capital
06/30/21 Colliers
New Senior Investment downgraded to Neutral from Buy at Colliers
06/30/21 Capital One
New Senior Investment downgraded to Equalweight from Overweight at Capital One
06/28/21 BMO Capital
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively'
VTR Ventas
$57.10 /

-0.32 (-0.56%)

06/30/21 Scotiabank
Ventas price target raised to $63 from $61 at Scotiabank
06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
VTR Ventas
$57.10 /

-0.32 (-0.56%)

SNR New Senior Investment
$8.78 /

-0.06 (-0.68%)

Recommendations
Ventas price target raised to $63 from $61 at Scotiabank » 09:14
06/30/21
06/30
09:14
06/30/21
09:14
VTR

Ventas

$57.42 /

-0.15 (-0.26%)

Scotiabank analyst…

Scotiabank analyst Nicholas Yulico raised the firm's price target on Ventas to $63 from $61 and keeps a Sector Perform rating on the shares. The analyst increased estimates to reflect the announced $2.3B acquisition of New Senior Investment Group. The transaction will increase Ventas's seniors housing operating exposure from 26% to 31%, Yulico tells investors in a research note. He believes the dal carries further net operating income upside potential.

ShowHide Related Items >><<
VTR Ventas
$57.42 /

-0.15 (-0.26%)

VTR Ventas
$57.42 /

-0.15 (-0.26%)

06/30/21 RBC Capital
Ventas price target raised to $65 from $62 at RBC Capital
06/28/21 BMO Capital
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively'
06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
VTR Ventas
$57.42 /

-0.15 (-0.26%)

VTR Ventas
$57.42 /

-0.15 (-0.26%)

Recommendations
Ventas price target raised to $65 from $62 at RBC Capital » 08:58
06/30/21
06/30
08:58
06/30/21
08:58
VTR

Ventas

$57.42 /

-0.15 (-0.26%)

, SNR

New Senior Investment

$8.84 /

-0.09 (-1.01%)

RBC Capital analyst…

RBC Capital analyst Michael Carroll raised the firm's price target on Ventas (VTR) to $65 from $62 and keeps an Outperform rating on the shares. The analyst is citing positive senior housing trends and the company's recently announced New Senior Investment (SNR) acquisition. Carroll adds that the seniors housing recovery has been strong quarter-to-date and is expected to further accelerate in June and likely beyond.

ShowHide Related Items >><<
VTR Ventas
$57.42 /

-0.15 (-0.26%)

SNR New Senior Investment
$8.84 /

-0.09 (-1.01%)

VTR Ventas
$57.42 /

-0.15 (-0.26%)

06/28/21 BMO Capital
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively'
06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
06/11/21 Barclays
Ventas upgraded to Overweight from Equal Weight at Barclays
SNR New Senior Investment
$8.84 /

-0.09 (-1.01%)

06/30/21 Colliers
New Senior Investment downgraded to Neutral from Buy at Colliers
06/30/21 Capital One
New Senior Investment downgraded to Equalweight from Overweight at Capital One
03/15/21 Morgan Stanley
Morgan Stanley upgrades Physicians Realty to Overweight after underperformance
VTR Ventas
$57.42 /

-0.15 (-0.26%)

VTR Ventas
$57.42 /

-0.15 (-0.26%)

SNR New Senior Investment
$8.84 /

-0.09 (-1.01%)

Hot Stocks
Ventas names Terika Richardson as new COO » 16:00
06/29/21
06/29
16:00
06/29/21
16:00
VTR

Ventas

$57.68 /

-0.34 (-0.59%)

Ardent Health Services…

Ardent Health Services has appointed Terika Richardson chief operating officer, effective September 7. In her new role, Richardson will oversee the operations of Ardent's 30 hospitals and more than 200 sites of care across six states. Richardson most recently served as president of Advocate Aurora Health's Central Chicagoland Patient Service Area where she oversaw the operations and strategic growth of their hospitals, clinics and ambulatory operations.

ShowHide Related Items >><<
VTR Ventas
$57.68 /

-0.34 (-0.59%)

VTR Ventas
$57.68 /

-0.34 (-0.59%)

06/28/21 BMO Capital
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively'
06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
06/11/21 Barclays
Ventas upgraded to Overweight from Equal Weight at Barclays
VTR Ventas
$57.68 /

-0.34 (-0.59%)

VTR Ventas
$57.68 /

-0.34 (-0.59%)

On The Fly
Wall Street in Fives - Must Read Lists for Monday » 16:07
06/28/21
06/28
16:07
06/28/21
16:07
BBQ

BBQ Holdings

$17.76 /

+1.25 (+7.57%)

, AAL

American Airlines

$21.34 /

-0.905 (-4.07%)

, DAL

Delta Air Lines

$43.04 /

-1.395 (-3.14%)

, UAL

United Airlines

$52.35 /

-1.51 (-2.80%)

, NTLA

Intellia Therapeutics

$134.40 /

+45.7 (+51.52%)

, JNJ

Johnson & Johnson

$164.15 /

-0.08 (-0.05%)

, TSLA

Tesla

$689.14 /

+16.81 (+2.50%)

, PFG

Principal Financial

$63.26 /

-1.1 (-1.71%)

, FB

Facebook

$355.79 /

+14.29 (+4.18%)

, NKTR

Nektar

$17.75 /

+0.46 (+2.66%)

, GBT

Global Blood Therapeutics

$33.24 /

-3.21 (-8.81%)

, MMS

Maximus

$87.37 /

-4.935 (-5.35%)

, SQSP

Squarespace

$63.33 /

-0.87 (-1.36%)

, DLO

dLocal

$51.49 /

+3.72 (+7.79%)

, BA

Boeing

$240.01 /

-8.29 (-3.34%)

, EADSY

Airbus

$32.25 /

-0.74 (-2.24%)

, AVGO

Broadcom

$473.27 /

+10.7902 (+2.33%)

, MRVL

Marvell

$58.64 /

+2.28 (+4.05%)

, NVDA

Nvidia

$799.35 /

+38.36 (+5.04%)

, AAPL

Apple

$134.87 /

+1.75 (+1.31%)

, AVXL

Anavex

$28.89 /

+4.08 (+16.44%)

, SNR

New Senior Investment

$8.94 /

+2.005 (+28.91%)

, VTR

Ventas

$58.01 /

-0.32 (-0.55%)

, JKS

JinkoSolar

$52.57 /

+9.57 (+22.26%)

, CVM

CEL-SCI

$13.84 /

-11.47 (-45.32%)

, BIIB

Biogen

$339.98 /

-7.98 (-2.29%)

, PERI

Perion Network

$21.66 /

+2.99 (+16.01%)

, DBGI

Digital Brands

$5.40 /

-0.06 (-1.10%)

, JENGQ

Just Energy

$1.74 /

+ (+0.00%)

, MU

Micron

$83.41 /

+1.36 (+1.66%)

, WBA

Walgreens Boots Alliance

$52.26 /

+0.1 (+0.19%)

, STZ

Constellation Brands

$229.49 /

+1.06 (+0.46%)

Get caught up quickly on…

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$52.26 /

+0.1 (+0.19%)

VTR Ventas
$58.01 /

-0.32 (-0.55%)

UAL United Airlines
$52.35 /

-1.51 (-2.80%)

TSLA Tesla
$689.14 /

+16.81 (+2.50%)

STZ Constellation Brands
$229.49 /

+1.06 (+0.46%)

SQSP Squarespace
$63.33 /

-0.87 (-1.36%)

SNR New Senior Investment
$8.94 /

+2.005 (+28.91%)

PFG Principal Financial
$63.26 /

-1.1 (-1.71%)

PERI Perion Network
$21.66 /

+2.99 (+16.01%)

NVDA Nvidia
$799.35 /

+38.36 (+5.04%)

NTLA Intellia Therapeutics
$134.40 /

+45.7 (+51.52%)

NKTR Nektar
$17.75 /

+0.46 (+2.66%)

MU Micron
$83.41 /

+1.36 (+1.66%)

MRVL Marvell
$58.64 /

+2.28 (+4.05%)

MMS Maximus
$87.37 /

-4.935 (-5.35%)

JNJ Johnson & Johnson
$164.15 /

-0.08 (-0.05%)

JKS JinkoSolar
$52.57 /

+9.57 (+22.26%)

JENGQ Just Energy
$1.74 /

+ (+0.00%)

GBT Global Blood Therapeutics
$33.24 /

-3.21 (-8.81%)

FB Facebook
$355.79 /

+14.29 (+4.18%)

EADSY Airbus
$32.25 /

-0.74 (-2.24%)

DBGI Digital Brands
$5.40 /

-0.06 (-1.10%)

DAL Delta Air Lines
$43.04 /

-1.395 (-3.14%)

CVM CEL-SCI
$13.84 /

-11.47 (-45.32%)

BIIB Biogen
$339.98 /

-7.98 (-2.29%)

BBQ BBQ Holdings
$17.76 /

+1.25 (+7.57%)

BA Boeing
$240.01 /

-8.29 (-3.34%)

AVXL Anavex
$28.89 /

+4.08 (+16.44%)

AVGO Broadcom
$473.27 /

+10.7902 (+2.33%)

AAPL Apple
$134.87 /

+1.75 (+1.31%)

AAL American Airlines
$21.34 /

-0.905 (-4.07%)

BBQ BBQ Holdings
$17.76 /

+1.25 (+7.57%)

06/28/21 Craig-Hallum
BBQ Holdings price target raised to $25 from $20 at Craig-Hallum
05/20/21 Craig-Hallum
BBQ Holdings price target raised to $20 from $15 at Craig-Hallum
04/06/21 Craig-Hallum
BBQ Holdings upgraded to Buy from Hold at Craig-Hallum
AAL American Airlines
$21.34 /

-0.905 (-4.07%)

06/09/21 MKM Partners
American Airlines initiated with a Buy at MKM Partners
06/09/21 MKM Partners
American Airlines initiated with a Buy at MKM Partners
04/23/21 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
04/23/21 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
DAL Delta Air Lines
$43.04 /

-1.395 (-3.14%)

06/18/21 Wolfe Research
Wolfe Research upgrades three airlines on 'pent-up demand scenario'
06/18/21 Wolfe Research
Delta Air Lines upgraded to Outperform from Underperform at Wolfe Research
06/09/21 MKM Partners
MKM Partners starts Delta Air Lines at Buy, calls stock Top Pick
06/09/21 MKM Partners
Delta Air Lines initiated with a Buy at MKM Partners
UAL United Airlines
$52.35 /

-1.51 (-2.80%)

06/18/21 Wolfe Research
United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
06/09/21 MKM Partners
United Airlines initiated with a Neutral at MKM Partners
04/21/21 Deutsche Bank
United Airlines named 'Catalyst Call: Buy' at Deutsche Bank
NTLA Intellia Therapeutics
$134.40 /

+45.7 (+51.52%)

06/28/21 RBC Capital
Intellia Therapeutics price target raised to $150 from $110 at RBC Capital
06/28/21 Piper Sandler
Alnylam shares down on NTLA-2001 data, says Piper Sandler
06/28/21 Chardan
Alnylam investors 'should take notice' of Intellia POC data, says Chardan
06/28/21 Wedbush
Intellia Therapeutics price target raised to $87 from $73 at Wedbush
JNJ Johnson & Johnson
$164.15 /

-0.08 (-0.05%)

06/28/21 Cantor Fitzgerald
J&J opioid settlement removes share overhang, says Cantor Fitzgerald
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
TSLA Tesla
$689.14 /

+16.81 (+2.50%)

06/28/21 Wedbush
Tesla China recall 'a clear negative PR moment,' says Wedbush
06/28/21 Bernstein
Survey shows Tesla owners still fervent supporters but more open, says Bernstein
06/22/21 Piper Sandler
Electric vehicles will represent 94% of new car sales by 2040, says Piper
06/14/21 Canaccord
Tesla price target lowered to $812 from $974 at Canaccord
PFG Principal Financial
$63.26 /

-1.1 (-1.71%)

06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Piper Sandler
Principal Financial downgraded to Neutral from Overweight at Piper Sandler
04/12/21 Barclays
Principal Financial price target raised to $69 from $65 at Barclays
04/05/21 JPMorgan
Principal Financial price target raised to $66 from $55 at JPMorgan
FB Facebook
$355.79 /

+14.29 (+4.18%)

06/28/21 Evercore ISI
Evercore ISI sees 'increasingly successful' VR product cycle at Facebook
06/24/21 Cowen
Cowen says vote on first antitrust bill encouraging for big tech
06/08/21 Tigress Financial
Tigress sees Facebook shares going to $430 within 12 months
06/08/21 Wedbush
Apple WWDC 'all about iOS 15, new Macs,' says Wedbush
NKTR Nektar
$17.75 /

+0.46 (+2.66%)

06/28/21
Fly Intel: Top five analyst upgrades
06/28/21 Stifel
Stifel upgrades Nektar to Buy ahead of lung cancer data
06/28/21 Stifel
Nektar upgraded to Buy from Hold at Stifel
05/18/21 Goldman Sachs
Nektar assumed with a Neutral at Goldman Sachs
GBT Global Blood Therapeutics
$33.24 /

-3.21 (-8.81%)

06/28/21
Fly Intel: Top five analyst downgrades
06/28/21 JPMorgan
JPMorgan downgrades Global Blood Therapeutics after physician survey
06/28/21 JPMorgan
Global Blood Therapeutics downgraded to Neutral from Overweight at JPMorgan
05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
MMS Maximus
$87.37 /

-4.935 (-5.35%)

06/28/21 Raymond James
Maximus downgraded to Outperform from Strong Buy at Raymond James
04/22/21 Canaccord
Maximus price target raised to $95 from $79 at Canaccord
07/08/20
Fly Intel: Top five analyst upgrades
SQSP Squarespace
$63.33 /

-0.87 (-1.36%)

06/28/21
Fly Intel: Top five analyst initiations
06/28/21 Wedbush
Wedbush sees opportunity reflected in Squarespace stock, initiates with Neutral
06/28/21 Wedbush
Squarespace initiated with a Neutral at Wedbush
06/28/21 Barclays
Squarespace initiated with an Equal Weight at Barclays
DLO dLocal
$51.49 /

+3.72 (+7.79%)

06/28/21 Citi
dLocal initiated with a Neutral at Citi
06/28/21 Morgan Stanley
dLocal initiated with an Overweight at Morgan Stanley
06/28/21 BofA
dLocal initiated with a Buy at BofA
BA Boeing
$240.01 /

-8.29 (-3.34%)

06/15/21 Berenberg
Boeing price target raised to $245 from $215 at Berenberg
06/10/21 Jefferies
Boeing shares could move up 5% on China recertification, says Jefferies
06/09/21 Susquehanna
Boeing estimates lowered on light May deliveries, says Susquehanna
06/03/21 Morgan Stanley
Morgan Stanley says recovery tailwinds can offset new launch headwinds at Boeing
EADSY Airbus
$32.25 /

-0.74 (-2.24%)

06/15/21 Berenberg
Airbus price target raised to EUR 140 from EUR 110 at Berenberg
06/11/21 Credit Suisse
Airbus assumed with an Outperform at Credit Suisse
06/02/21 Barclays
Airbus price target raised to EUR 138 from EUR 113 at Barclays
06/02/21
Fly Intel: Top five analyst upgrades
AVGO Broadcom
$473.27 /

+10.7902 (+2.33%)

06/28/21 Citi
Nvidia's Arm deals takes 'big step forward' with support, says Citi
06/07/21 Baird
Broadcom price target raised to $550 from $500 at Baird
06/07/21 Baird
Broadcom price target raised to $550 from $500 at Baird
06/04/21 Morgan Stanley
Broadcom price target raised to $555 from $538 at Morgan Stanley
MRVL Marvell
$58.64 /

+2.28 (+4.05%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Needham
Marvell price target raised to $55 from $50 at Needham
06/08/21 Craig-Hallum
Marvell price target raised to $63 from $52 at Craig-Hallum
NVDA Nvidia
$799.35 /

+38.36 (+5.04%)

06/23/21 Wells Fargo
Nvidia price target raised to $875 from $715 at Wells Fargo
06/23/21 Tigress Financial
Nvidia shares going to $920 in 12 months, says Tigress Financial
06/22/21 Raymond James
Nvidia price target raised to $900 from $750 at Raymond James
AAPL Apple
$134.87 /

+1.75 (+1.31%)

06/24/21 Morgan Stanley
Concerns about Apple's iPhone 'S' cycle overblown, says Morgan Stanley
06/21/21 Wedbush
Apple likely to launch iPhone 13 in third week of September, says Wedbush
06/17/21 Loop Capital
Loop Capital starts Cirrus Logic at Buy, cites content gains at Apple
AVXL Anavex
$28.89 /

+4.08 (+16.44%)

06/28/21 Cantor Fitzgerald
Anavex price target raised to $40 from $31 at Cantor Fitzgerald
06/28/21 Cantor Fitzgerald
Anavex price target raised to $40 from $31 at Cantor Fitzgerald
06/28/21 H.C. Wainwright
Anavex price target raised to $39 from $25 at H.C. Wainwright
06/21/21 Dawson James
Anavex price target raised to $35 from $19 at Dawson James
SNR New Senior Investment
$8.94 /

+2.005 (+28.91%)

06/28/21 BMO Capital
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively'
03/15/21 Morgan Stanley
Morgan Stanley upgrades Physicians Realty to Overweight after underperformance
08/21/20 Colliers
New Senior Investment initiated with a Buy at Colliers
VTR Ventas
$58.01 /

-0.32 (-0.55%)

06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
06/11/21 Barclays
Ventas upgraded to Overweight from Equal Weight at Barclays
JKS JinkoSolar
$52.57 /

+9.57 (+22.26%)

04/16/21 UBS
JinkoSolar upgraded to Neutral from Sell at UBS
04/12/21 GLJ Research
JinkoSolar businss model 'simply not sustainable,' says GLJ Research
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Roth Capital
JinkoSolar downgraded to Neutral from Buy at Roth Capital
CVM CEL-SCI
$13.84 /

-11.47 (-45.32%)

BIIB Biogen
$339.98 /

-7.98 (-2.29%)

06/28/21 RBC Capital
Biogen price target lowered to $354 from $400 at RBC Capital
06/25/21 BTIG
Prothena price target raised to $65 from $29 at BTIG
06/24/21 Mizuho
Mizuho enthusiasm 'tempered somewhat' after speaking to Eli Lilly
06/24/21 Cowen
Eli Lilly price target raised to $250 from $235 at Cowen
PERI Perion Network
$21.66 /

+2.99 (+16.01%)

06/28/21 Stifel
Perion Network price target raised to $21 at Stifel after preliminary Q2 report
06/28/21 Lake Street
Perion Network price target raised to $29 at Lake Street after pre-announcement
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 Stifel
Perion Network initiated with a Hold at Stifel
DBGI Digital Brands
$5.40 /

-0.06 (-1.10%)

JENGQ Just Energy
$1.74 /

+ (+0.00%)

MU Micron
$83.41 /

+1.36 (+1.66%)

06/29/21 Citi
Citi reiterates $135 target on Micron, says results to beat esimates
06/28/21 Rosenblatt
Micron reiterated as top pick at Rosenblatt ahead of Q3 earnings
06/25/21 Cowen
Micron should be bought heading into quarterly results, says Cowen
06/21/21 Citi
Citi says buy Micron on dips despite less upside potential in Q4
WBA Walgreens Boots Alliance
$52.26 /

+0.1 (+0.19%)

05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
05/26/21 Deutsche Bank
Amazon unlikely to enter retail pharmacy business, says Deutsche Bank
05/12/21 Mizuho
Walgreens Boots Alliance price target raised to $55 from $47 at Mizuho
04/14/21 Morgan Stanley
Walgreens Boots Alliance price target raised to $60 from $52 at Morgan Stanley
STZ Constellation Brands
$229.49 /

+1.06 (+0.46%)

06/28/21 Jefferies
Constellation Brands price target raised to $298 from $295 at Jefferies
06/24/21 Cowen
Constellation Brands post-earnings weakness a buying opportunity, says Cowen
06/18/21 OTR Global
Constellation Brands view downgraded to Mixed from Positive at OTR Global
05/25/21
Fly Intel: Top five analyst initiations
WBA Walgreens Boots Alliance
$52.26 /

+0.1 (+0.19%)

VTR Ventas
$58.01 /

-0.32 (-0.55%)

UAL United Airlines
$52.35 /

-1.51 (-2.80%)

TSLA Tesla
$689.14 /

+16.81 (+2.50%)

STZ Constellation Brands
$229.49 /

+1.06 (+0.46%)

PFG Principal Financial
$63.26 /

-1.1 (-1.71%)

PERI Perion Network
$21.66 /

+2.99 (+16.01%)

NVDA Nvidia
$799.35 /

+38.36 (+5.04%)

NTLA Intellia Therapeutics
$134.40 /

+45.7 (+51.52%)

NKTR Nektar
$17.75 /

+0.46 (+2.66%)

MU Micron
$83.41 /

+1.36 (+1.66%)

MRVL Marvell
$58.64 /

+2.28 (+4.05%)

MMS Maximus
$87.37 /

-4.935 (-5.35%)

JNJ Johnson & Johnson
$164.15 /

-0.08 (-0.05%)

JKS JinkoSolar
$52.57 /

+9.57 (+22.26%)

JENGQ Just Energy
$1.74 /

+ (+0.00%)

GBT Global Blood Therapeutics
$33.24 /

-3.21 (-8.81%)

FB Facebook
$355.79 /

+14.29 (+4.18%)

EADSY Airbus
$32.25 /

-0.74 (-2.24%)

DBGI Digital Brands
$5.40 /

-0.06 (-1.10%)

DAL Delta Air Lines
$43.04 /

-1.395 (-3.14%)

BIIB Biogen
$339.98 /

-7.98 (-2.29%)

BBQ BBQ Holdings
$17.76 /

+1.25 (+7.57%)

BA Boeing
$240.01 /

-8.29 (-3.34%)

AVXL Anavex
$28.89 /

+4.08 (+16.44%)

AVGO Broadcom
$473.27 /

+10.7902 (+2.33%)

AAPL Apple
$134.87 /

+1.75 (+1.31%)

AAL American Airlines
$21.34 /

-0.905 (-4.07%)

  • 09
    Jun
  • 03
    Jun
  • 14
    May
  • 19
    May
  • 20
    Jan
  • 02
    Dec
  • 10
    Nov
WBA Walgreens Boots Alliance
$52.26 /

+0.1 (+0.19%)

UAL United Airlines
$52.35 /

-1.51 (-2.80%)

TSLA Tesla
$689.14 /

+16.81 (+2.50%)

STZ Constellation Brands
$229.49 /

+1.06 (+0.46%)

NVDA Nvidia
$799.35 /

+38.36 (+5.04%)

MU Micron
$83.41 /

+1.36 (+1.66%)

MRVL Marvell
$58.64 /

+2.28 (+4.05%)

JNJ Johnson & Johnson
$164.15 /

-0.08 (-0.05%)

JKS JinkoSolar
$52.57 /

+9.57 (+22.26%)

FB Facebook
$355.79 /

+14.29 (+4.18%)

EADSY Airbus
$32.25 /

-0.74 (-2.24%)

DLO dLocal
$51.49 /

+3.72 (+7.79%)

DAL Delta Air Lines
$43.04 /

-1.395 (-3.14%)

CVM CEL-SCI
$13.84 /

-11.47 (-45.32%)

BIIB Biogen
$339.98 /

-7.98 (-2.29%)

BA Boeing
$240.01 /

-8.29 (-3.34%)

AVGO Broadcom
$473.27 /

+10.7902 (+2.33%)

AAPL Apple
$134.87 /

+1.75 (+1.31%)

AAL American Airlines
$21.34 /

-0.905 (-4.07%)

WBA Walgreens Boots Alliance
$52.26 /

+0.1 (+0.19%)

UAL United Airlines
$52.35 /

-1.51 (-2.80%)

TSLA Tesla
$689.14 /

+16.81 (+2.50%)

STZ Constellation Brands
$229.49 /

+1.06 (+0.46%)

SQSP Squarespace
$63.33 /

-0.87 (-1.36%)

PERI Perion Network
$21.66 /

+2.99 (+16.01%)

NVDA Nvidia
$799.35 /

+38.36 (+5.04%)

NTLA Intellia Therapeutics
$134.40 /

+45.7 (+51.52%)

MRVL Marvell
$58.64 /

+2.28 (+4.05%)

JNJ Johnson & Johnson
$164.15 /

-0.08 (-0.05%)

JKS JinkoSolar
$52.57 /

+9.57 (+22.26%)

GBT Global Blood Therapeutics
$33.24 /

-3.21 (-8.81%)

FB Facebook
$355.79 /

+14.29 (+4.18%)

EADSY Airbus
$32.25 /

-0.74 (-2.24%)

DLO dLocal
$51.49 /

+3.72 (+7.79%)

DBGI Digital Brands
$5.40 /

-0.06 (-1.10%)

DAL Delta Air Lines
$43.04 /

-1.395 (-3.14%)

CVM CEL-SCI
$13.84 /

-11.47 (-45.32%)

BIIB Biogen
$339.98 /

-7.98 (-2.29%)

BBQ BBQ Holdings
$17.76 /

+1.25 (+7.57%)

AVXL Anavex
$28.89 /

+4.08 (+16.44%)

AVGO Broadcom
$473.27 /

+10.7902 (+2.33%)

AAPL Apple
$134.87 /

+1.75 (+1.31%)

AAL American Airlines
$21.34 /

-0.905 (-4.07%)

WBA Walgreens Boots Alliance
$52.26 /

+0.1 (+0.19%)

UAL United Airlines
$52.35 /

-1.51 (-2.80%)

TSLA Tesla
$689.14 /

+16.81 (+2.50%)

STZ Constellation Brands
$229.49 /

+1.06 (+0.46%)

SQSP Squarespace
$63.33 /

-0.87 (-1.36%)

PFG Principal Financial
$63.26 /

-1.1 (-1.71%)

NVDA Nvidia
$799.35 /

+38.36 (+5.04%)

MU Micron
$83.41 /

+1.36 (+1.66%)

MRVL Marvell
$58.64 /

+2.28 (+4.05%)

JNJ Johnson & Johnson
$164.15 /

-0.08 (-0.05%)

JKS JinkoSolar
$52.57 /

+9.57 (+22.26%)

JENGQ Just Energy
$1.74 /

+ (+0.00%)

FB Facebook
$355.79 /

+14.29 (+4.18%)

DLO dLocal
$51.49 /

+3.72 (+7.79%)

DAL Delta Air Lines
$43.04 /

-1.395 (-3.14%)

CVM CEL-SCI
$13.84 /

-11.47 (-45.32%)

BIIB Biogen
$339.98 /

-7.98 (-2.29%)

BA Boeing
$240.01 /

-8.29 (-3.34%)

AVGO Broadcom
$473.27 /

+10.7902 (+2.33%)

AAPL Apple
$134.87 /

+1.75 (+1.31%)

AAL American Airlines
$21.34 /

-0.905 (-4.07%)

Recommendations
BMO Capital views Ventas' $2.3B New Senior acquisition 'positively' » 11:39
06/28/21
06/28
11:39
06/28/21
11:39
VTR

Ventas

$57.45 /

-0.88 (-1.51%)

, SNR

New Senior Investment

$8.89 /

+1.955 (+28.19%)

BMO Capital analyst Juan…

BMO Capital analyst Juan Sanabria notes that Ventas (VTR) announced it has entered into a merger agreement with New Senior Investment Group (SNR) in a $2.3B transaction valuing the senior housing portfolio at $185K/unit. The analyst views the transaction positively. New Senior Investment Group adds earnings upside near the senior housing trough via a middle market, independent living portfolio at an attractive yield at a discount to replacement cost, Sanabria adds. At current valuation levels, the analyst believes Ventas needs to continue to execute on external acquisitions. He has an Underperform rating and a price target of $57 on Ventas' shares.

ShowHide Related Items >><<
VTR Ventas
$57.45 /

-0.88 (-1.51%)

SNR New Senior Investment
$8.89 /

+1.955 (+28.19%)

VTR Ventas
$57.45 /

-0.88 (-1.51%)

06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
06/11/21 Barclays
Ventas upgraded to Overweight from Equal Weight at Barclays
06/03/21 Deutsche Bank
Ventas price target raised to $61 from $50 at Deutsche Bank
SNR New Senior Investment
$8.89 /

+1.955 (+28.19%)

03/15/21 Morgan Stanley
Morgan Stanley upgrades Physicians Realty to Overweight after underperformance
08/21/20 Colliers
New Senior Investment initiated with a Buy at Colliers
VTR Ventas
$57.45 /

-0.88 (-1.51%)

Hot Stocks
Ventas to acquire New Senior in all equity $2.3B transaction » 09:15
06/28/21
06/28
09:15
06/28/21
09:15
VTR

Ventas

$58.28 /

+0.315 (+0.54%)

, SNR

New Senior Investment

$6.94 /

+0.005 (+0.07%)

Ventas (VTR) and New…

Ventas (VTR) and New Senior Investment Group (SNR) announced that they have entered into a definitive merger agreement pursuant to which Ventas will acquire New Senior in an all-stock transaction valued at approximately $2.3B including $1.5B of New Senior debt. Under the terms of the agreement, New Senior shareholders will receive 0.1561 shares of newly issued Ventas stock per share of New Senior common stock. Based on the closing price of Ventas common stock on June 25, 2021, this represents approximately $9.10 per New Senior share, a 31% equity premium based on New Senior's 30-day trading average, and a 10% premium on New Senior's total enterprise value. "Building on the strong momentum we are experiencing in our business, we are delighted to announce this strategic and accretive acquisition with New Senior that expands Ventas's position in senior housing at an important inflection point in the cycle as the senior housing industry rebounds," said Debra A. Cafaro, Ventas Chairman and CEO.

ShowHide Related Items >><<
VTR Ventas
$58.28 /

+0.315 (+0.54%)

VTR Ventas
$58.28 /

+0.315 (+0.54%)

06/15/21 Raymond James
Ventas price target raised to $65 from $61 at Raymond James
06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
06/11/21 Barclays
Ventas upgraded to Overweight from Equal Weight at Barclays
06/03/21 Deutsche Bank
Ventas price target raised to $61 from $50 at Deutsche Bank
SNR New Senior Investment
$6.94 /

+0.005 (+0.07%)

03/15/21 Morgan Stanley
Morgan Stanley upgrades Physicians Realty to Overweight after underperformance
08/21/20 Colliers
New Senior Investment initiated with a Buy at Colliers
VTR Ventas
$58.28 /

+0.315 (+0.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.